company background image
605016 logo

Shandong Bailong Chuangyuan Bio-Tech SHSE:605016 Stock Report

Last Price

CN¥15.84

Market Cap

CN¥5.1b

7D

-5.9%

1Y

-11.2%

Updated

23 Sep, 2024

Data

Company Financials +

Shandong Bailong Chuangyuan Bio-Tech Co., Ltd.

SHSE:605016 Stock Report

Market Cap: CN¥5.1b

Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Shandong Bailong Chuangyuan Bio-Tech
Historical stock prices
Current Share PriceCN¥15.84
52 Week HighCN¥23.96
52 Week LowCN¥14.54
Beta0.34
11 Month Change8.79%
3 Month Change-23.44%
1 Year Change-11.24%
33 Year Change16.65%
5 Year Changen/a
Change since IPO91.74%

Recent News & Updates

Here's Why Shandong Bailong Chuangyuan Bio-Tech (SHSE:605016) Has Caught The Eye Of Investors

Aug 23
Here's Why Shandong Bailong Chuangyuan Bio-Tech (SHSE:605016) Has Caught The Eye Of Investors

Returns On Capital At Shandong Bailong Chuangyuan Bio-Tech (SHSE:605016) Have Hit The Brakes

Jun 26
Returns On Capital At Shandong Bailong Chuangyuan Bio-Tech (SHSE:605016) Have Hit The Brakes

Recent updates

Here's Why Shandong Bailong Chuangyuan Bio-Tech (SHSE:605016) Has Caught The Eye Of Investors

Aug 23
Here's Why Shandong Bailong Chuangyuan Bio-Tech (SHSE:605016) Has Caught The Eye Of Investors

Returns On Capital At Shandong Bailong Chuangyuan Bio-Tech (SHSE:605016) Have Hit The Brakes

Jun 26
Returns On Capital At Shandong Bailong Chuangyuan Bio-Tech (SHSE:605016) Have Hit The Brakes

Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (SHSE:605016) Analysts Are More Bearish Than They Used To Be

May 06
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (SHSE:605016) Analysts Are More Bearish Than They Used To Be

Concerns Surrounding Shandong Bailong Chuangyuan Bio-Tech's (SHSE:605016) Performance

May 03
Concerns Surrounding Shandong Bailong Chuangyuan Bio-Tech's (SHSE:605016) Performance

If EPS Growth Is Important To You, Shandong Bailong Chuangyuan Bio-Tech (SHSE:605016) Presents An Opportunity

Mar 27
If EPS Growth Is Important To You, Shandong Bailong Chuangyuan Bio-Tech (SHSE:605016) Presents An Opportunity

Shareholder Returns

605016CN FoodCN Market
7D-5.9%0.8%1.1%
1Y-11.2%-22.9%-20.4%

Return vs Industry: 605016 exceeded the CN Food industry which returned -22.9% over the past year.

Return vs Market: 605016 exceeded the CN Market which returned -20.4% over the past year.

Price Volatility

Is 605016's price volatile compared to industry and market?
605016 volatility
605016 Average Weekly Movement5.9%
Food Industry Average Movement4.7%
Market Average Movement5.4%
10% most volatile stocks in CN Market8.5%
10% least volatile stocks in CN Market3.6%

Stable Share Price: 605016's share price has been volatile over the past 3 months.

Volatility Over Time: 605016's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2005742Hongjian Zhuowww.sdblcy.com

Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. engages in the production and sale of functional sugar in China and internationally. The company offers dietary fibers, including polydextrose and resistant dextrin; prebiotics, such as fructo-oligosaccharide, isomalto- oligosaccharide, galacto- oligosaccharide, and xylo- oligosaccharide.

Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. Fundamentals Summary

How do Shandong Bailong Chuangyuan Bio-Tech's earnings and revenue compare to its market cap?
605016 fundamental statistics
Market capCN¥5.12b
Earnings (TTM)CN¥221.46m
Revenue (TTM)CN¥986.85m

23.1x

P/E Ratio

5.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
605016 income statement (TTM)
RevenueCN¥986.85m
Cost of RevenueCN¥665.39m
Gross ProfitCN¥321.46m
Other ExpensesCN¥100.01m
EarningsCN¥221.46m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.69
Gross Margin32.57%
Net Profit Margin22.44%
Debt/Equity Ratio4.5%

How did 605016 perform over the long term?

See historical performance and comparison

Dividends

0.4%

Current Dividend Yield

31%

Payout Ratio